Pregabalin |
![]() Last updated: 16/09/2025 |
![]() |
(Not known by any other names) |
|
![]() |
|
A neuroactive veterinary drug used for dedation and as an anticonvulsant | |
---|---|---|
|
Used to assist with acute anxiety and fear associated with transportation and veterinary visits as well as treating epilepsy, chronic pain and seizures | |
|
Cats |
Approval status |
|
Approved - usually available as a prescription only medicine to be authorised by a veterinarian (POM-V) | |
---|---|---|
|
Approved |
Chemical structure |
|
Substance is isomeric existing in the (R)- and (S)-forms. Pregabalin is the (S)-isomer and the potent of the two. | |
---|---|---|
|
C₈H₁₇NO₂ | |
|
CC(C)CC(CC(=O)O)CN | |
|
CC(C)C[C@@H](CC(=O)O)CN | |
|
AYXYPKUFHZROOJ-ZETCQYMHSA-N | |
|
InChI=1S/C8H17NO2/c1-6(2)3-7(5-9)4-8(10)11/h6-7H,3-5,9H2,1-2H3,(H,10,11)/t7-/m0/s1 | |
|
Yes |
|
![]() |
Common Name | Relationship | Link |
---|---|---|
(R)-pregabalin | Isomer | ![]() |
pregabalin | - | ![]() |
(S)-pregabalin | Isomer | ![]() |
General status |
|
Sedative | |
---|---|---|
|
Alkylated analog of GABA | |
|
- | |
|
- | |
|
Synthetic | |
|
Binds to the auxiliary subunit (alpha2-delta protein) of voltage-gated calcium channels in the CNS thereby reducing the release of various neurotransmitters and producing its anxiolytic effect. | |
|
[Alpha2-delta subunits, Binder] | |
|
148553-50-8 | |
|
604-639-1 | |
|
- | |
|
- | |
|
5486971 | |
|
Nervous system, other antiepileptics | |
|
QN03AX16 | |
|
UK: Class C, Schedule 3 | |
|
- | |
|
159.23 | |
|
(3S)-3-(aminomethyl)-5-methylhexanoic acid | |
|
(3S)-3-(aminomethyl)-5-methylhexanoic acid | |
|
- | |
|
- | |
|
- | |
|
- | |
|
Off-white coloured crystalline solid |
Commercial |
|
|
|||
---|---|---|---|---|
|
Current | |||
|
1990, disscovered; 1995, clinical trials began | |||
|
|
|||
|
|
|||
|
Usually supplied as an oral solution, off-label using human brands | |||
|
Pregabalin is synthesised through a multi-step chemical process that begins with the preparation of key intermediates, most notably (S)-3-aminomethyl-5-methylhexanoic acid, which ensures the correct stereochemistry of the final molecule. The synthesis typically involves asymmetric reactions, including reductive amination, functional group protection/deprotection, and selective oxidation. Advanced catalysts and precise reaction conditions are used to build the pregabalin structure. Once the crude compound is formed, it undergoes rigorous purification, including crystallisation and filtration, to achieve pharmaceutical-grade purity. | |||
|
Published GHG data is not available for most pharmaceuticals. However, according to industry, global averages suggest producing 1 kg of a typical active pharmaceutical ingredient can range from 10 to 100 kg CO₂e for small molecule drugs and potentially up to 1000 kg CO₂e for complex biologicals such as vaccines, depending on the drug type, its formulation, complexity of synthesis, solvent recovery, and energy sources used. |
|
![]() |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
11300 | Q3 Q = Miscellaneous data from online sources 3 = Unverified data of known source |
High | ||||||||
|
- | - | - | ||||||||
|
176 | Q3 Q = Miscellaneous data from online sources 3 = Unverified data of known source |
- | ||||||||
|
145 | Q3 Q = Miscellaneous data from online sources 3 = Unverified data of known source |
- | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
2.00 X 1001 | Calculated | - | |||||||
|
1.3 | Q3 Q = Miscellaneous data from online sources 3 = Unverified data of known source |
Low | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
4.2 | Q3 Q = Miscellaneous data from online sources 3 = Unverified data of known source |
- | ||||||||
pKa(2) = 10.6 | |||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- |
Degradation |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
As this parameter is not normally measured directly, a surrogate measure is used: ‘Photochemical oxidative DT₅₀’. Where data is available, this can be found in the Fate Indices section below. | ||||||||||
|
- |
Soil adsorption and mobility |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | ||||||||||
|
- | ||||||||||
|
- |
Fate indices |
|
|
|
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||||||||||||||||||||
|
|
- | - | - | |||||||||||||||||||||||||
|
- | - |
Known metabolites |
None
|
![]() |
Terrestrial ecotoxicology |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
> 5000 | E4 E = Manufacturers safety data sheets Rat4 = Verified data |
Low | ||||||||
|
|
- | - | - | |||||||
|
- | - | |||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
- | |||||||||||
|
- | - | - | ||||||||
- | |||||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - |
Aquatic ecotoxicology |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
> 1000 | E4 E = Manufacturers safety data sheets Oncorhynchus mykiss4 = Verified data |
Low | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
> 1000 | E4 E = Manufacturers safety data sheets Daphnia magna4 = Verified data |
Low | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
> 300 | E4 E = Manufacturers safety data sheets Scenedesmus quadricauda4 = Verified data |
Low | ||||||||
|
|
- | - | - |
|
- | - | - | |||
|
- | - | - |
|
![]() |
General |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||
|
> 5000 | E4 E = Manufacturers safety data sheets Rat4 = Verified data |
Low | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
Pattern of use is unlikely to result in toxicological relevant exposure | |||||||||
|
Pattern of use is unlikely to result in toxicological relevant exposure | ||||||||||
|
Elimination is primarily as an unchanged drug by renal excretion usually within 7 hrs | E4 E = Manufacturers safety data sheets 4 = Verified data |
- |
Health issues |
|
|
||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Originally approved in US as an anti-epileptic & anticonvulsant drug May cause severe allergic reaction Possible liver toxin |
Handling issues |
|
|
|||
---|---|---|---|---|
|
Corrosive Incompatible with strong oxidising agents |
|||
|
Health: H373, H361, H318 | |||
|
Not listed (Not listed) | |||
|
Not registered | |||
|
- | |||
|
Shelf-life for sale is 2 years but once package is opened shelf-life reduces to 6 months. Store in a refrigerator (2-8 DegC). |
|
![]() |
|
|
||
---|---|---|---|
|
pregabalin | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- |
Record last updated: | 16/09/2025 |
Contact: | aeru@herts.ac.uk |
Please cite as: | Lewis, K.A., Tzilivakis, J., Warner, D. and Green, A. (2016) An international database for pesticide risk assessments and management. Human and Ecological Risk Assessment: An International Journal, 22(4), 1050-1064. DOI: 10.1080/10807039.2015.1133242 |